{"gene":"BLOC1S6","run_date":"2026-06-09T22:02:44","timeline":{"discoveries":[{"year":2002,"finding":"Pallidin (PLDN/BLOC1S6) protein binds directly to syntaxin-13, a member of the syntaxin family of SNARE proteins involved in intracellular membrane fusion, suggesting a role for pallidin in membrane fusion events required for melanosome biogenesis.","method":"Protein-protein interaction (binding assay); review of prior experimental findings","journal":"Pigment cell research","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — single binding assay reported across multiple papers, foundational finding replicated in subsequent work (PMID:21665000)","pmids":["11936273"],"is_preprint":false},{"year":2011,"finding":"A homozygous nonsense mutation in PLDN abolishes full-length pallidin protein expression; an alternative splice-skipping transcript, if translated, correctly localizes to early endosomes but fails to interact with syntaxin-13, and patient melanocytes show aberrant TYRP1 localization with increased plasma-membrane trafficking and failure to reach melanosomes.","method":"Patient cell analysis, Western blot, immunofluorescence localization, co-immunoprecipitation (syntaxin-13 interaction of alternative isoform)","journal":"American journal of human genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal functional validation: loss of syntaxin-13 interaction and aberrant TYRP1 trafficking demonstrated by multiple orthogonal methods in patient cells","pmids":["21665000"],"is_preprint":false},{"year":2010,"finding":"BLOC-1 (containing pallidin/PLDN) acts as a brain-region-specific regulator of AP-3, selectively reducing AP-3 and AP-3 cargo immunoreactivity in presynaptic compartments of the dentate gyrus but not the striatum; loss-of-function of BLOC-1 (pallid/Pldn^pa) alters synaptic vesicle composition in an anatomically restricted manner.","method":"Quantitative immunoelectron microscopy and light microscopy in Pldn^pa/pa loss-of-function mouse model","journal":"The Journal of neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean genetic loss-of-function with quantitative ultrastructural readout, single lab","pmids":["20089890"],"is_preprint":false},{"year":2017,"finding":"PLDN (BLOC1S6) is a direct transcriptional target of the hematopoietic transcription factor RUNX1; RUNX1 binds RUNX1 consensus sites in the PLDN promoter, and RUNX1 downregulation decreases PLDN promoter activity and pallidin protein expression, leading to impaired platelet dense granule (DG) formation and mislocalization of the DG marker CD63.","method":"Chromatin immunoprecipitation (ChIP), electrophoretic mobility shift assay (EMSA), luciferase reporter assay, RUNX1 overexpression/knockdown in HEL cells, mepacrine handling and CD63 localization assays","journal":"Journal of thrombosis and haemostasis : JTH","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — multiple orthogonal methods (ChIP, EMSA, reporter mutagenesis, functional cell assays) in single rigorous study establishing direct transcriptional regulation","pmids":["28075530"],"is_preprint":false},{"year":2021,"finding":"BLOC-1 (including pallidin/PLDN, encoded by Pldn^pa) is required for trafficking of the zinc transporter TMEM163 to perinuclear dense granule (DG) precursor compartments (late endosome marker-positive) in megakaryocytic cells; loss of BLOC-1 results in reduced TMEM163 levels and platelet DG deficiency with intracellular zinc accumulation.","method":"Quantitative proteomics in Pldn^pa-deficient mice, immunofluorescence colocalization in MEG-01 cells, platelet electron microscopy, Western blot","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — quantitative proteomics plus cellular trafficking assay, single lab, multiple orthogonal methods","pmids":["33513603"],"is_preprint":false},{"year":2016,"finding":"HPS9 (BLOC-1 subunit pallidin/PLDN) deficiency in mice results in defective regulated release of von Willebrand factor (VWF) after DDAVP stimulation, indicating a role for BLOC-1 in endothelial Weibel-Palade body function.","method":"DDAVP stimulation assay measuring VWF plasma levels in Pldn-deficient (pallid) mice; comparison with other HPS mouse models","journal":"Journal of genetics and genomics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo functional assay in genetic mouse model, single lab","pmids":["27889498"],"is_preprint":false},{"year":2018,"finding":"MLE-15 cells with CRISPR-introduced Bloc1s6 (HPS9) mutations show loss of protein targeting to lamellar bodies and increased expression of macrophage chemotactic protein-1 (MCP-1), paralleling findings in pallid AT2 cells, indicating that BLOC-1/pallidin deficiency promotes alveolar inflammation via MCP-1 upregulation.","method":"CRISPR/Cas9 gene editing, lamellar body organelle assay, surfactant protein B processing assay, MCP-1 expression measurement","journal":"American journal of respiratory cell and molecular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean genetic loss-of-function with defined cellular phenotype, multiple readouts, single lab","pmids":["29190429"],"is_preprint":false},{"year":2017,"finding":"BLOC-1 deficiency in pallid mice (null mutation in Bloc1s6) results in elevated hippocampal levels of the neurotransmitters glutamate and NAAG, decreased phenylalanine and tryptophan, and upregulation of the glutamine transporter SNAT1, revealing metabolic consequences of pallidin/BLOC-1 loss on amino acid and neurotransmitter homeostasis.","method":"Untargeted LC-MS metabolomics of hippocampal tissue from pallid mice, statistical pathway enrichment analysis, SNAT1 expression measurement","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — metabolomics with pathway validation in genetic mouse model, single lab","pmids":["28701731"],"is_preprint":false},{"year":2015,"finding":"Loss of Pldn function (pallid mutation) results in increased sensitivity of melanoma cells to cisplatin, vinblastine, and etoposide, with concomitant disruption of melanosome morphology and loss of mature melanosomes, establishing that PLDN/BLOC-1-dependent melanosome biogenesis contributes to chemotherapy resistance.","method":"Drug sensitivity assays (cisplatin, vinblastine, etoposide) comparing congenic Pldn-mutant and wild-type melanocytes/melanoma cells; melanosome morphology analysis","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic loss-of-function with defined pharmacological phenotype across multiple drug classes, single lab","pmids":["19155314"],"is_preprint":false}],"current_model":"BLOC1S6/PLDN encodes pallidin, an ~20-kDa subunit of the BLOC-1 complex that directly binds the endosomal t-SNARE syntaxin-13 to mediate membrane trafficking events required for biogenesis of lysosome-related organelles (melanosomes, platelet dense granules, lamellar bodies, synaptic vesicles); BLOC-1/pallidin is also required for trafficking of cargoes such as TYRP1 and TMEM163 to their correct organellar destinations, acts downstream of the transcription factor RUNX1 in megakaryocytes, and functions as a brain-region-specific regulator of AP-3-dependent synaptic vesicle composition in the dentate gyrus."},"narrative":{"mechanistic_narrative":"BLOC1S6 encodes pallidin, a subunit of the BLOC-1 complex that mediates membrane trafficking required for the biogenesis of lysosome-related organelles including melanosomes, platelet dense granules, and lamellar bodies [PMID:21665000, PMID:19155314]. At the molecular level, pallidin binds directly to the endosomal t-SNARE syntaxin-13, coupling BLOC-1 to membrane fusion machinery; a disease-associated isoform that retains early-endosomal localization but loses syntaxin-13 binding fails to support cargo delivery, and patient melanocytes lacking functional pallidin missort the melanosomal enzyme TYRP1 to the plasma membrane rather than to melanosomes [PMID:11936273, PMID:21665000]. BLOC-1/pallidin similarly governs trafficking of additional cargoes to their organellar destinations, routing the zinc transporter TMEM163 and the dense-granule marker CD63 to dense-granule precursor compartments, with loss causing platelet dense-granule deficiency [PMID:28075530, PMID:33513603]. Pallidin expression is driven transcriptionally by RUNX1, which binds the PLDN promoter and is required for normal pallidin levels and dense-granule formation in megakaryocytes [PMID:28075530]. In the nervous system, BLOC-1 acts as a brain-region-specific regulator of AP-3-dependent synaptic vesicle composition, selectively shaping presynaptic AP-3 cargo content in the dentate gyrus, and its loss perturbs hippocampal amino acid and neurotransmitter homeostasis [PMID:20089890, PMID:28701731]. The biallelic loss-of-function timeline establishes BLOC1S6 deficiency as a cause of a Hermansky-Pudlak-type syndrome (HPS9) [PMID:21665000].","teleology":[{"year":2002,"claim":"Established the core molecular interaction of pallidin by showing it binds the SNARE protein syntaxin-13, linking BLOC-1 to the membrane fusion machinery underlying melanosome biogenesis.","evidence":"Protein-protein binding assay reported across pigmentation studies","pmids":["11936273"],"confidence":"Medium","gaps":["Single binding assay without structural definition of the interface","Did not establish which trafficking step the interaction serves in vivo"]},{"year":2009,"claim":"Demonstrated that pallidin-dependent melanosome biogenesis has functional consequences beyond pigmentation, with loss sensitizing melanoma cells to multiple chemotherapeutic agents.","evidence":"Drug sensitivity assays and melanosome morphology in congenic Pldn-mutant melanocytes/melanoma cells","pmids":["19155314"],"confidence":"Medium","gaps":["Mechanism linking melanosome integrity to drug sequestration not resolved","Single lab, mouse-derived cells"]},{"year":2010,"claim":"Revealed an anatomically restricted neuronal role, showing BLOC-1 regulates AP-3 and AP-3 cargo content in dentate gyrus presynaptic compartments but not striatum.","evidence":"Quantitative immunoelectron and light microscopy in Pldn^pa loss-of-function mice","pmids":["20089890"],"confidence":"Medium","gaps":["Basis for brain-region selectivity unexplained","Functional impact on synaptic transmission not measured"]},{"year":2011,"claim":"Provided reciprocal functional validation in human disease, tying loss of pallidin and its syntaxin-13 interaction to aberrant TYRP1 trafficking and defining BLOC1S6 as an HPS gene.","evidence":"Patient cell analysis, Western blot, immunofluorescence, and co-IP of an alternative isoform","pmids":["21665000"],"confidence":"High","gaps":["Whether the alternative isoform contributes residual function in patients unclear","Did not define how syntaxin-13 binding mechanistically directs TYRP1 to melanosomes"]},{"year":2016,"claim":"Extended pallidin function to endothelial secretory organelles by showing BLOC-1 loss impairs regulated von Willebrand factor release from Weibel-Palade bodies.","evidence":"DDAVP stimulation and VWF measurement in Pldn-deficient mice","pmids":["27889498"],"confidence":"Medium","gaps":["Cargo or trafficking step in Weibel-Palade body biogenesis not identified","In vivo readout without cellular mechanism"]},{"year":2017,"claim":"Identified the upstream transcriptional control of PLDN by RUNX1, placing pallidin in a defined megakaryocytic gene program required for dense-granule formation.","evidence":"ChIP, EMSA, luciferase reporter mutagenesis, and RUNX1 gain/loss with CD63 localization assays in HEL cells","pmids":["28075530"],"confidence":"High","gaps":["Other transcriptional inputs to PLDN not mapped","Quantitative contribution of PLDN loss to RUNX1-deficient platelet phenotype undefined"]},{"year":2017,"claim":"Showed that BLOC-1 loss has downstream metabolic consequences, altering hippocampal neurotransmitter and amino acid levels and SNAT1 transporter expression.","evidence":"Untargeted LC-MS metabolomics and expression analysis of pallid mouse hippocampus","pmids":["28701731"],"confidence":"Medium","gaps":["Causal chain from trafficking defect to metabolite changes not established","Correlative pathway enrichment"]},{"year":2018,"claim":"Connected pallidin loss to lamellar body cargo targeting and a pro-inflammatory output, showing Bloc1s6 mutation impairs lamellar body protein targeting and upregulates MCP-1.","evidence":"CRISPR-edited MLE-15 cells with lamellar body, surfactant protein B processing, and MCP-1 assays","pmids":["29190429"],"confidence":"Medium","gaps":["Mechanism linking trafficking defect to MCP-1 induction unknown","Single lab, cell-line model"]},{"year":2021,"claim":"Identified TMEM163 as a BLOC-1-dependent cargo, mechanistically linking pallidin to zinc handling and dense-granule biogenesis.","evidence":"Quantitative proteomics in Pldn^pa mice, colocalization in MEG-01 cells, platelet EM and Western blot","pmids":["33513603"],"confidence":"Medium","gaps":["Whether BLOC-1 directly recognizes TMEM163 or acts indirectly not resolved","Single lab"]},{"year":null,"claim":"How pallidin within BLOC-1 selects distinct cargoes (TYRP1, TMEM163, CD63) for different lysosome-related organelles and how the syntaxin-13 interaction is regulated remain unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model of pallidin within assembled BLOC-1","Cargo-recognition determinants undefined","Mechanism coordinating BLOC-1 with AP-3 not established"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[0,1]}],"localization":[{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[1]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[4]}],"pathway":[{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[1,4]},{"term_id":"R-HSA-1852241","term_label":"Organelle biogenesis and maintenance","supporting_discovery_ids":[1,8]}],"complexes":["BLOC-1"],"partners":["STX12","RUNX1","TMEM163"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9UL45","full_name":"Biogenesis of lysosome-related organelles complex 1 subunit 6","aliases":["Pallid protein homolog","Pallidin","Syntaxin 13-interacting protein"],"length_aa":172,"mass_kda":19.7,"function":"Component of the BLOC-1 complex, a complex that is required for normal biogenesis of lysosome-related organelles (LRO), such as platelet dense granules and melanosomes. In concert with the AP-3 complex, the BLOC-1 complex is required to target membrane protein cargos into vesicles assembled at cell bodies for delivery into neurites and nerve terminals. The BLOC-1 complex, in association with SNARE proteins, is also proposed to be involved in neurite extension. May play a role in intracellular vesicle trafficking, particularly in the vesicle-docking and fusion process","subcellular_location":"Cytoplasm; Membrane","url":"https://www.uniprot.org/uniprotkb/Q9UL45/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/BLOC1S6","classification":"Not Classified","n_dependent_lines":4,"n_total_lines":1208,"dependency_fraction":0.0033112582781456954},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/BLOC1S6","total_profiled":1310},"omim":[{"mim_id":"615178","title":"KXDL MOTIF-CONTAINING PROTEIN 1; KXD1","url":"https://www.omim.org/entry/615178"},{"mim_id":"614171","title":"HERMANSKY-PUDLAK SYNDROME 9; HPS9","url":"https://www.omim.org/entry/614171"},{"mim_id":"609762","title":"BIOGENESIS OF LYSOSOME-RELATED ORGANELLES COMPLEX 1, SUBUNIT 3; BLOC1S3","url":"https://www.omim.org/entry/609762"},{"mim_id":"607289","title":"BIOGENESIS OF LYSOSOME-RELATED ORGANELLES COMPLEX 1, SUBUNIT 5; BLOC1S5","url":"https://www.omim.org/entry/607289"},{"mim_id":"604310","title":"BIOGENESIS OF LYSOSOME-RELATED ORGANELLES COMPLEX 1, SUBUNIT 6; BLOC1S6","url":"https://www.omim.org/entry/604310"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/BLOC1S6"},"hgnc":{"alias_symbol":["HPS9"],"prev_symbol":["PA","PLDN"]},"alphafold":{"accession":"Q9UL45","domains":[{"cath_id":"1.20.5","chopping":"48-132","consensus_level":"medium","plddt":97.1209,"start":48,"end":132}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UL45","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UL45-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UL45-F1-predicted_aligned_error_v6.png","plddt_mean":82.81},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=BLOC1S6","jax_strain_url":"https://www.jax.org/strain/search?query=BLOC1S6"},"sequence":{"accession":"Q9UL45","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9UL45.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9UL45/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UL45"}},"corpus_meta":[{"pmid":"21665000","id":"PMC_21665000","title":"A BLOC-1 mutation screen reveals that PLDN is mutated in Hermansky-Pudlak Syndrome type 9.","date":"2011","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21665000","citation_count":75,"is_preprint":false},{"pmid":"24134793","id":"PMC_24134793","title":"Clinical, laboratory and molecular signs of immunodeficiency in patients with partial oculo-cutaneous albinism.","date":"2013","source":"Orphanet journal of rare diseases","url":"https://pubmed.ncbi.nlm.nih.gov/24134793","citation_count":58,"is_preprint":false},{"pmid":"20089890","id":"PMC_20089890","title":"Hermansky-Pudlak protein complexes, AP-3 and BLOC-1, differentially regulate presynaptic composition in the striatum and hippocampus.","date":"2010","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/20089890","citation_count":53,"is_preprint":false},{"pmid":"17618940","id":"PMC_17618940","title":"Dysbindin (DTNBP1) and the biogenesis of lysosome-related organelles complex 1 (BLOC-1): main and epistatic gene effects are potential contributors to schizophrenia susceptibility.","date":"2007","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/17618940","citation_count":48,"is_preprint":false},{"pmid":"19155314","id":"PMC_19155314","title":"Multidrug resistance decreases with mutations of melanosomal regulatory genes.","date":"2009","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/19155314","citation_count":33,"is_preprint":false},{"pmid":"16127425","id":"PMC_16127425","title":"Analysis of the tight skin (Tsk1/+) mouse as a model for testing antifibrotic agents.","date":"2005","source":"Laboratory investigation; a journal of technical methods and pathology","url":"https://pubmed.ncbi.nlm.nih.gov/16127425","citation_count":32,"is_preprint":false},{"pmid":"32969595","id":"PMC_32969595","title":"Current landscape of Oculocutaneous Albinism in Japan.","date":"2020","source":"Pigment cell & melanoma research","url":"https://pubmed.ncbi.nlm.nih.gov/32969595","citation_count":25,"is_preprint":false},{"pmid":"26333666","id":"PMC_26333666","title":"A Genome-wide Scan for Selective Sweeps in Racing Horses.","date":"2015","source":"Asian-Australasian journal of animal sciences","url":"https://pubmed.ncbi.nlm.nih.gov/26333666","citation_count":24,"is_preprint":false},{"pmid":"27889498","id":"PMC_27889498","title":"BLOC-2 subunit HPS6 deficiency affects the tubulation and secretion of von Willebrand factor from mouse endothelial cells.","date":"2016","source":"Journal of genetics and genomics = Yi chuan xue bao","url":"https://pubmed.ncbi.nlm.nih.gov/27889498","citation_count":22,"is_preprint":false},{"pmid":"33513603","id":"PMC_33513603","title":"A zinc transporter, transmembrane protein 163, is critical for the biogenesis of platelet dense granules.","date":"2021","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/33513603","citation_count":21,"is_preprint":false},{"pmid":"28075530","id":"PMC_28075530","title":"Dysregulation of PLDN (pallidin) is a mechanism for platelet dense granule deficiency in RUNX1 haplodeficiency.","date":"2017","source":"Journal of thrombosis and haemostasis : JTH","url":"https://pubmed.ncbi.nlm.nih.gov/28075530","citation_count":20,"is_preprint":false},{"pmid":"11936273","id":"PMC_11936273","title":"The pallidin (Pldn) gene and the role of SNARE proteins in melanosome biogenesis.","date":"2002","source":"Pigment cell research","url":"https://pubmed.ncbi.nlm.nih.gov/11936273","citation_count":18,"is_preprint":false},{"pmid":"23563589","id":"PMC_23563589","title":"An association study of the Hermansky-Pudlak syndrome type 4 gene in schizophrenic patients.","date":"2013","source":"Psychiatric genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23563589","citation_count":13,"is_preprint":false},{"pmid":"29190429","id":"PMC_29190429","title":"Gene-edited MLE-15 Cells as a Model for the Hermansky-Pudlak Syndromes.","date":"2018","source":"American journal of respiratory cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/29190429","citation_count":12,"is_preprint":false},{"pmid":"33543539","id":"PMC_33543539","title":"The first Hermansky-Pudlak syndrome type 9 patient with two novel variants in Chinese population.","date":"2021","source":"The Journal of dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/33543539","citation_count":12,"is_preprint":false},{"pmid":"32245340","id":"PMC_32245340","title":"A new case with Hermansky-Pudlak syndrome type 9, a rare cause of syndromic albinism with severe defect of platelets dense bodies.","date":"2020","source":"Platelets","url":"https://pubmed.ncbi.nlm.nih.gov/32245340","citation_count":12,"is_preprint":false},{"pmid":"32687635","id":"PMC_32687635","title":"Novel variants in the BLOC1S3 gene in patients presenting a mild form of Hermansky-Pudlak syndrome.","date":"2020","source":"Pigment cell & melanoma research","url":"https://pubmed.ncbi.nlm.nih.gov/32687635","citation_count":9,"is_preprint":false},{"pmid":"31619213","id":"PMC_31619213","title":"Novel genetic variant of HPS1 gene in Hermansky-Pudlak syndrome with fulminant progression of pulmonary fibrosis: a case report.","date":"2019","source":"BMC pulmonary medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31619213","citation_count":9,"is_preprint":false},{"pmid":"28701731","id":"PMC_28701731","title":"BLOC-1 deficiency causes alterations in amino acid profile and in phospholipid and adenosine metabolism in the postnatal mouse hippocampus.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28701731","citation_count":8,"is_preprint":false},{"pmid":"39847262","id":"PMC_39847262","title":"Painful diabetic neuropathy is associated with accelerated epigenetic aging.","date":"2025","source":"GeroScience","url":"https://pubmed.ncbi.nlm.nih.gov/39847262","citation_count":7,"is_preprint":false},{"pmid":"24987500","id":"PMC_24987500","title":"Highly expressed genes in human high grade gliomas: immunohistochemical analysis of data from the human protein atlas.","date":"2014","source":"Neurology international","url":"https://pubmed.ncbi.nlm.nih.gov/24987500","citation_count":7,"is_preprint":false},{"pmid":"35847855","id":"PMC_35847855","title":"From Transcriptomics, Metabolomics to Functional Studies: Extracellular ATP Induces TGF-β-Like Epithelial Mesenchymal Transition in Lung Cancer Cells.","date":"2022","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/35847855","citation_count":6,"is_preprint":false},{"pmid":"27345974","id":"PMC_27345974","title":"Generation of Hermansky-Pudlak Syndrome Type 1 (HPS1) induced pluripotent stem cells (iPSCs).","date":"2016","source":"Stem cell research","url":"https://pubmed.ncbi.nlm.nih.gov/27345974","citation_count":5,"is_preprint":false},{"pmid":"39457042","id":"PMC_39457042","title":"Masks of Albinism: Clinical Spectrum of Hermansky-Pudlak Syndrome.","date":"2024","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/39457042","citation_count":3,"is_preprint":false},{"pmid":"36430862","id":"PMC_36430862","title":"Diagnosing Czech Patients with Inherited Platelet Disorders.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/36430862","citation_count":3,"is_preprint":false},{"pmid":"35488210","id":"PMC_35488210","title":"NGS-based targeted sequencing identified two novel variants in Southwestern Chinese families with oculocutaneous albinism.","date":"2022","source":"BMC genomics","url":"https://pubmed.ncbi.nlm.nih.gov/35488210","citation_count":3,"is_preprint":false},{"pmid":"39187771","id":"PMC_39187771","title":"A novel deletion in the BLOC1S6 Gene Associated with Hermansky-Pudlak syndrome type 9 (HPS-9).","date":"2024","source":"BMC genomics","url":"https://pubmed.ncbi.nlm.nih.gov/39187771","citation_count":2,"is_preprint":false},{"pmid":"27702429","id":"PMC_27702429","title":"Conventional deep pressure algometry is not suitable for clinical assessment of nociception in painless diabetic neuropathy.","date":"2016","source":"Diabetic foot & ankle","url":"https://pubmed.ncbi.nlm.nih.gov/27702429","citation_count":2,"is_preprint":false},{"pmid":"40924632","id":"PMC_40924632","title":"Peroxisome proliferator-activated receptor pathway and key genes in cerebellar dysfunction induced by chronic intermittent alcohol exposure: a transcriptomic study.","date":"2025","source":"Neurological research","url":"https://pubmed.ncbi.nlm.nih.gov/40924632","citation_count":0,"is_preprint":false},{"pmid":"41312429","id":"PMC_41312429","title":"Comparative RNA-Seq Analysis of Colon Spheroids and Patient-derived Tissues Identifies Non-Canonical Transcript Isoforms of Protein-Coding Genes Implicated in Colon Carcinogenesis.","date":"2025","source":"Cancer informatics","url":"https://pubmed.ncbi.nlm.nih.gov/41312429","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":17411,"output_tokens":2335,"usd":0.043629,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":9464,"output_tokens":3008,"usd":0.06126,"stage2_stop_reason":"end_turn"},"total_usd":0.104889,"stage1_batch_id":"msgbatch_0179Z2pxRYBsXi2xADneafRw","stage2_batch_id":"msgbatch_01LaY9ZaVdgjWArcZo9eqQE5","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2002,\n      \"finding\": \"Pallidin (PLDN/BLOC1S6) protein binds directly to syntaxin-13, a member of the syntaxin family of SNARE proteins involved in intracellular membrane fusion, suggesting a role for pallidin in membrane fusion events required for melanosome biogenesis.\",\n      \"method\": \"Protein-protein interaction (binding assay); review of prior experimental findings\",\n      \"journal\": \"Pigment cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — single binding assay reported across multiple papers, foundational finding replicated in subsequent work (PMID:21665000)\",\n      \"pmids\": [\"11936273\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"A homozygous nonsense mutation in PLDN abolishes full-length pallidin protein expression; an alternative splice-skipping transcript, if translated, correctly localizes to early endosomes but fails to interact with syntaxin-13, and patient melanocytes show aberrant TYRP1 localization with increased plasma-membrane trafficking and failure to reach melanosomes.\",\n      \"method\": \"Patient cell analysis, Western blot, immunofluorescence localization, co-immunoprecipitation (syntaxin-13 interaction of alternative isoform)\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal functional validation: loss of syntaxin-13 interaction and aberrant TYRP1 trafficking demonstrated by multiple orthogonal methods in patient cells\",\n      \"pmids\": [\"21665000\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"BLOC-1 (containing pallidin/PLDN) acts as a brain-region-specific regulator of AP-3, selectively reducing AP-3 and AP-3 cargo immunoreactivity in presynaptic compartments of the dentate gyrus but not the striatum; loss-of-function of BLOC-1 (pallid/Pldn^pa) alters synaptic vesicle composition in an anatomically restricted manner.\",\n      \"method\": \"Quantitative immunoelectron microscopy and light microscopy in Pldn^pa/pa loss-of-function mouse model\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean genetic loss-of-function with quantitative ultrastructural readout, single lab\",\n      \"pmids\": [\"20089890\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"PLDN (BLOC1S6) is a direct transcriptional target of the hematopoietic transcription factor RUNX1; RUNX1 binds RUNX1 consensus sites in the PLDN promoter, and RUNX1 downregulation decreases PLDN promoter activity and pallidin protein expression, leading to impaired platelet dense granule (DG) formation and mislocalization of the DG marker CD63.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP), electrophoretic mobility shift assay (EMSA), luciferase reporter assay, RUNX1 overexpression/knockdown in HEL cells, mepacrine handling and CD63 localization assays\",\n      \"journal\": \"Journal of thrombosis and haemostasis : JTH\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — multiple orthogonal methods (ChIP, EMSA, reporter mutagenesis, functional cell assays) in single rigorous study establishing direct transcriptional regulation\",\n      \"pmids\": [\"28075530\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"BLOC-1 (including pallidin/PLDN, encoded by Pldn^pa) is required for trafficking of the zinc transporter TMEM163 to perinuclear dense granule (DG) precursor compartments (late endosome marker-positive) in megakaryocytic cells; loss of BLOC-1 results in reduced TMEM163 levels and platelet DG deficiency with intracellular zinc accumulation.\",\n      \"method\": \"Quantitative proteomics in Pldn^pa-deficient mice, immunofluorescence colocalization in MEG-01 cells, platelet electron microscopy, Western blot\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — quantitative proteomics plus cellular trafficking assay, single lab, multiple orthogonal methods\",\n      \"pmids\": [\"33513603\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"HPS9 (BLOC-1 subunit pallidin/PLDN) deficiency in mice results in defective regulated release of von Willebrand factor (VWF) after DDAVP stimulation, indicating a role for BLOC-1 in endothelial Weibel-Palade body function.\",\n      \"method\": \"DDAVP stimulation assay measuring VWF plasma levels in Pldn-deficient (pallid) mice; comparison with other HPS mouse models\",\n      \"journal\": \"Journal of genetics and genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo functional assay in genetic mouse model, single lab\",\n      \"pmids\": [\"27889498\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"MLE-15 cells with CRISPR-introduced Bloc1s6 (HPS9) mutations show loss of protein targeting to lamellar bodies and increased expression of macrophage chemotactic protein-1 (MCP-1), paralleling findings in pallid AT2 cells, indicating that BLOC-1/pallidin deficiency promotes alveolar inflammation via MCP-1 upregulation.\",\n      \"method\": \"CRISPR/Cas9 gene editing, lamellar body organelle assay, surfactant protein B processing assay, MCP-1 expression measurement\",\n      \"journal\": \"American journal of respiratory cell and molecular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean genetic loss-of-function with defined cellular phenotype, multiple readouts, single lab\",\n      \"pmids\": [\"29190429\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"BLOC-1 deficiency in pallid mice (null mutation in Bloc1s6) results in elevated hippocampal levels of the neurotransmitters glutamate and NAAG, decreased phenylalanine and tryptophan, and upregulation of the glutamine transporter SNAT1, revealing metabolic consequences of pallidin/BLOC-1 loss on amino acid and neurotransmitter homeostasis.\",\n      \"method\": \"Untargeted LC-MS metabolomics of hippocampal tissue from pallid mice, statistical pathway enrichment analysis, SNAT1 expression measurement\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — metabolomics with pathway validation in genetic mouse model, single lab\",\n      \"pmids\": [\"28701731\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Loss of Pldn function (pallid mutation) results in increased sensitivity of melanoma cells to cisplatin, vinblastine, and etoposide, with concomitant disruption of melanosome morphology and loss of mature melanosomes, establishing that PLDN/BLOC-1-dependent melanosome biogenesis contributes to chemotherapy resistance.\",\n      \"method\": \"Drug sensitivity assays (cisplatin, vinblastine, etoposide) comparing congenic Pldn-mutant and wild-type melanocytes/melanoma cells; melanosome morphology analysis\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic loss-of-function with defined pharmacological phenotype across multiple drug classes, single lab\",\n      \"pmids\": [\"19155314\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"BLOC1S6/PLDN encodes pallidin, an ~20-kDa subunit of the BLOC-1 complex that directly binds the endosomal t-SNARE syntaxin-13 to mediate membrane trafficking events required for biogenesis of lysosome-related organelles (melanosomes, platelet dense granules, lamellar bodies, synaptic vesicles); BLOC-1/pallidin is also required for trafficking of cargoes such as TYRP1 and TMEM163 to their correct organellar destinations, acts downstream of the transcription factor RUNX1 in megakaryocytes, and functions as a brain-region-specific regulator of AP-3-dependent synaptic vesicle composition in the dentate gyrus.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"BLOC1S6 encodes pallidin, a subunit of the BLOC-1 complex that mediates membrane trafficking required for the biogenesis of lysosome-related organelles including melanosomes, platelet dense granules, and lamellar bodies [#1, #8]. At the molecular level, pallidin binds directly to the endosomal t-SNARE syntaxin-13, coupling BLOC-1 to membrane fusion machinery; a disease-associated isoform that retains early-endosomal localization but loses syntaxin-13 binding fails to support cargo delivery, and patient melanocytes lacking functional pallidin missort the melanosomal enzyme TYRP1 to the plasma membrane rather than to melanosomes [#0, #1]. BLOC-1/pallidin similarly governs trafficking of additional cargoes to their organellar destinations, routing the zinc transporter TMEM163 and the dense-granule marker CD63 to dense-granule precursor compartments, with loss causing platelet dense-granule deficiency [#3, #4]. Pallidin expression is driven transcriptionally by RUNX1, which binds the PLDN promoter and is required for normal pallidin levels and dense-granule formation in megakaryocytes [#3]. In the nervous system, BLOC-1 acts as a brain-region-specific regulator of AP-3-dependent synaptic vesicle composition, selectively shaping presynaptic AP-3 cargo content in the dentate gyrus, and its loss perturbs hippocampal amino acid and neurotransmitter homeostasis [#2, #7]. The biallelic loss-of-function timeline establishes BLOC1S6 deficiency as a cause of a Hermansky-Pudlak-type syndrome (HPS9) [#1].\",\n  \"teleology\": [\n    {\n      \"year\": 2002,\n      \"claim\": \"Established the core molecular interaction of pallidin by showing it binds the SNARE protein syntaxin-13, linking BLOC-1 to the membrane fusion machinery underlying melanosome biogenesis.\",\n      \"evidence\": \"Protein-protein binding assay reported across pigmentation studies\",\n      \"pmids\": [\"11936273\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single binding assay without structural definition of the interface\", \"Did not establish which trafficking step the interaction serves in vivo\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Demonstrated that pallidin-dependent melanosome biogenesis has functional consequences beyond pigmentation, with loss sensitizing melanoma cells to multiple chemotherapeutic agents.\",\n      \"evidence\": \"Drug sensitivity assays and melanosome morphology in congenic Pldn-mutant melanocytes/melanoma cells\",\n      \"pmids\": [\"19155314\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism linking melanosome integrity to drug sequestration not resolved\", \"Single lab, mouse-derived cells\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Revealed an anatomically restricted neuronal role, showing BLOC-1 regulates AP-3 and AP-3 cargo content in dentate gyrus presynaptic compartments but not striatum.\",\n      \"evidence\": \"Quantitative immunoelectron and light microscopy in Pldn^pa loss-of-function mice\",\n      \"pmids\": [\"20089890\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Basis for brain-region selectivity unexplained\", \"Functional impact on synaptic transmission not measured\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Provided reciprocal functional validation in human disease, tying loss of pallidin and its syntaxin-13 interaction to aberrant TYRP1 trafficking and defining BLOC1S6 as an HPS gene.\",\n      \"evidence\": \"Patient cell analysis, Western blot, immunofluorescence, and co-IP of an alternative isoform\",\n      \"pmids\": [\"21665000\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether the alternative isoform contributes residual function in patients unclear\", \"Did not define how syntaxin-13 binding mechanistically directs TYRP1 to melanosomes\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Extended pallidin function to endothelial secretory organelles by showing BLOC-1 loss impairs regulated von Willebrand factor release from Weibel-Palade bodies.\",\n      \"evidence\": \"DDAVP stimulation and VWF measurement in Pldn-deficient mice\",\n      \"pmids\": [\"27889498\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Cargo or trafficking step in Weibel-Palade body biogenesis not identified\", \"In vivo readout without cellular mechanism\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Identified the upstream transcriptional control of PLDN by RUNX1, placing pallidin in a defined megakaryocytic gene program required for dense-granule formation.\",\n      \"evidence\": \"ChIP, EMSA, luciferase reporter mutagenesis, and RUNX1 gain/loss with CD63 localization assays in HEL cells\",\n      \"pmids\": [\"28075530\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Other transcriptional inputs to PLDN not mapped\", \"Quantitative contribution of PLDN loss to RUNX1-deficient platelet phenotype undefined\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Showed that BLOC-1 loss has downstream metabolic consequences, altering hippocampal neurotransmitter and amino acid levels and SNAT1 transporter expression.\",\n      \"evidence\": \"Untargeted LC-MS metabolomics and expression analysis of pallid mouse hippocampus\",\n      \"pmids\": [\"28701731\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Causal chain from trafficking defect to metabolite changes not established\", \"Correlative pathway enrichment\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Connected pallidin loss to lamellar body cargo targeting and a pro-inflammatory output, showing Bloc1s6 mutation impairs lamellar body protein targeting and upregulates MCP-1.\",\n      \"evidence\": \"CRISPR-edited MLE-15 cells with lamellar body, surfactant protein B processing, and MCP-1 assays\",\n      \"pmids\": [\"29190429\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism linking trafficking defect to MCP-1 induction unknown\", \"Single lab, cell-line model\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Identified TMEM163 as a BLOC-1-dependent cargo, mechanistically linking pallidin to zinc handling and dense-granule biogenesis.\",\n      \"evidence\": \"Quantitative proteomics in Pldn^pa mice, colocalization in MEG-01 cells, platelet EM and Western blot\",\n      \"pmids\": [\"33513603\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether BLOC-1 directly recognizes TMEM163 or acts indirectly not resolved\", \"Single lab\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How pallidin within BLOC-1 selects distinct cargoes (TYRP1, TMEM163, CD63) for different lysosome-related organelles and how the syntaxin-13 interaction is regulated remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structural model of pallidin within assembled BLOC-1\", \"Cargo-recognition determinants undefined\", \"Mechanism coordinating BLOC-1 with AP-3 not established\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [0, 1]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [1]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [4]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [1, 4]},\n      {\"term_id\": \"R-HSA-1852241\", \"supporting_discovery_ids\": [1, 8]}\n    ],\n    \"complexes\": [\"BLOC-1\"],\n    \"partners\": [\"STX12\", \"RUNX1\", \"TMEM163\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}